Readystate Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$737K Buy
+1,500
New +$814K 0.03% 423
2025
Q2
Sell
-4,300
Closed -$2.14M 921
2025
Q1
$2.14M Hold
4,300
0.07% 317
2024
Q4
$2.24M Sell
4,300
-26,600
-86% -$14.6M 0.07% 286
2024
Q3
$19.1M Buy
30,900
+29,700
+2,475% +$17.6M 0.36% 37
2024
Q2
$664K Sell
1,200
-34,200
-97% -$19.6M 0.02% 436
2024
Q1
$20.6M Buy
35,400
+35,000
+8,750% +$19.6M 0.29% 48
2023
Q4
$212K Buy
+400
New +$194K 0.01% 527

Other funds holding TMO

Readystate Asset Management's TMO Position: Q2 2025 in Review

Readystate Asset Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 691 shares — an estimated $344K sold.

Readystate Asset Management first reported a position in TMO in Q3 2024 and held it in 3 quarters. The position peaked at $1.15M in Q4 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Readystate Asset Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Readystate Asset Management sold 691 Thermo Fisher Scientific shares in Q2 2025, an estimated $344K.
  • Readystate Asset Management first reported a position in Thermo Fisher Scientific in Q3 2024 and held it in 3 quarters.
  • Readystate Asset Management's Thermo Fisher Scientific position peaked at $1.15M in Q4 2024.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.